• Citer

Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with her2-positive breast cancer

par Palmieri, Carlo;Gojis, Ondrej;Januszewski, Adam;Lewanski, Conrad;Asher, Rebecca;Lythgoe, Daniel;de Azambuja, Evandro ;Beresford, Mark;Howell, Sacha S.J.;Macpherson, Iain R J;Yan, Kelvin;Ades Moraes, Felipe ;Riddle, Pippa;Ahmed, Riz;Owadally, Waheeda;Stanley, Barbara;Shah, Deep
Référence Oncotarget, 7, 11, page (13209-13220)
Publication Publié, 2016-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Neoadjuvant chemotherapy and trastuzumab versus neoadjuvant chemotherapy followed by post-operative trastuzumab for patients with her2-positive breast cancer
Auteur:	Palmieri, Carlo; Gojis, Ondrej; Januszewski, Adam; Lewanski, Conrad; Asher, Rebecca; Lythgoe, Daniel; de Azambuja, Evandro; Beresford, Mark; Howell, Sacha S.J.; Macpherson, Iain R J; Yan, Kelvin; Ades Moraes, Felipe; Riddle, Pippa; Ahmed, Riz; Owadally, Waheeda; Stanley, Barbara; Shah, Deep
Informations sur la publication:	Oncotarget, 7, 11, page (13209-13220)
Statut de publication:	Publié, 2016-03
Sujet CREF:	Psychiatrie
Mots-clés:	Breast
	Clinical section
	Concomitant
	Neoadjuvant
	Sequential
	Trastuzumab
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1949-2553
	info:doi/10.18632/oncotarget.4801
	info:scp/84962838939